For the quarter ending 2026-03-31, EVEX had $17,835K increase in cash & cash equivalents over the period. -$68,639K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -68,813 | -63,919 | -46,866 | -113,470 |
| Depreciation and amortization | 394 | 388 | 353 | 189 |
| Non-cash lease expenses | 42 | 35 | 132 | 337 |
| Unrealized loss (gain) on exchange rate changes | -2,447 | 1,386 | -1,063 | -2,216 |
| Share-based compensation | 1,108 | 1,092 | 86 | 3,139 |
| Warrant expenses | - | 0 | - | - |
| Warrants remeasurement gain (loss) | 598 | -413 | 6,441 | -6,156 |
| Deferred income taxes | 0 | -1,279 | - | - |
| Accrued interest on related party loan receivable, net | - | 0 | 0 | 0 |
| Non-cash tax expense | - | 0 | - | - |
| Accrued interest on financial investments, net | -216 | 616 | 24 | 1,192 |
| Other assets | -1,093 | 6,962 | 1,181 | 1,816 |
| Related party receivables | -42 | 10 | 59 | -468 |
| Accounts payable | -540 | 1,163 | -2,397 | 976 |
| Related party payables | -9,272 | 32,486 | 4,381 | 5,757 |
| Other payables | 5,768 | 12,659 | -3,021 | 16,717 |
| Net cash used by operating activities | -68,113 | -25,934 | -53,975 | -80,523 |
| Redemptions of financial investments | 79,000 | 76,000 | 66,000 | 155,000 |
| Purchases of financial investments | 110,000 | 12,000 | 209,000 | 108,000 |
| Related party loan collected (disbursed) | - | 0 | - | - |
| Collection of related party loan | - | - | 0 | - |
| Intangible assets, net | - | 2,180 | - | - |
| Expenditures for property, plant and equipment | 526 | 4,101 | 6,732 | 1,722 |
| Net cash provided (used) by investing activities | -31,526 | 57,719 | -149,732 | 45,278 |
| Proceeds from issuance of common stock, net of fees to investors | - | 0 | 226,336 | - |
| Non-investor equity issuance costs | - | -5 | 8,932 | - |
| Repayment of long-term debt principal | 50,736 | - | - | - |
| Proceeds from debt | 167,919 | 13,062 | 12,459 | 20,813 |
| Tax withholding on share-based compensation | - | 0 | 0 | 157 |
| Proceeds from exercised warrants | - | 0 | 0 | - |
| Non-creditor debt issuance costs | 121 | 286 | 0 | 178 |
| Net cash provided by financing activities | 117,062 | 12,779 | 229,863 | 20,479 |
| Effect of exchange rate changes on cash and cash equivalents | 412 | -378 | -264 | -65 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 17,835 | 44,187 | 25,892 | -14,832 |
| Cash, cash equivalents and restricted cash at beginning of period | 111,613 | 67,426 | 56,366 | - |
| Cash, cash equivalents and restricted cash at end of period | 129,448 | 111,613 | 67,426 | - |
Eve Holding, Inc. (EVEX)
Eve Holding, Inc. (EVEX)